Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital
Stock Information for Alzamend Neuro Inc.
Loading
Please wait while we load your information from QuoteMedia.